Clinical trial
PK of Rivaroxaban in Bariatric Patients - Extension
NCT02832947
Study timeline
Study start (unknown)2016-02-01Date precision: month
Registry last updated2017-04-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prophylaxis of Venous Thromboembolismunresolved
Interventions
Rivaroxaban 10 mgDRUG · verified · RxNorm: rivaroxaban 10 MG
Sponsors & collaborators
Insel Gruppe AG, University Hospital Bernlead sponsor
University of Lausanne Hospitalscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02832947 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.